The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
Tôru Kondo, Akio Mori, Stephanie Darmanin, S. Hashino, Junji Tanaka, Masahiro Asaka
Abstract
Open-access reader
Tôru Kondo, Akio Mori, Stephanie Darmanin, S. Hashino, Junji Tanaka, Masahiro Asaka
Abstract
Open-access reader
The majority of acute promyelocytic leukemia (APL) cases are characterized by the expression of the chimeric fusion gene PML-RARA . Although the PML-RARA fusion gene is detected in more than 95% of APL cases, RARA has also been found to fuse with other partner genes in some APL variants. To date,
OpenAlex reports 95 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The majority of acute promyelocytic leukemia (APL) cases are characterized by the expression of the chimeric fusion gene PML-RARA . Although the PML-RARA fusion gene is detected in more than 95% of APL cases, RARA has also been found to fuse with other partner genes in some APL variants. To date,
Key concepts: Acute promyelocytic leukemia, Fusion gene, Medicine, Leukemia, Gene, Immunology, Cancer research, Virology